Meningococcal Vaccines Market Is Set to Garner Staggering Revenues by 2021
Meningococcal vaccines are used in the treatment of meningitis, septicemia, meningococcemia and pneumonia. Meningitis is characterized by inflammation of the membranes covering the brain and spinal cord. This type of inflammation is caused by infection of bacteria, viruses and by drugs.
View full press release